临床试验

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT：NCT06898515 · RECRUITING

NCT编号NCT06898515

状态RECRUITING

开始日期2025-07-14

SponsorReprieve Cardiovascular, Inc (INDUSTRY)

First posted2025-03-27

Last updated2026-10-08

简要摘要

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。